FDA Reverses Course On Exclusivity For New Drug Combos
In a major break with two decades of policy, the U.S. Food and Drug Administration on Friday said new prescription drugs that contain both original and previously approved active ingredients will...To view the full article, register now.
Already a subscriber? Click here to view full article